{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:12:25Z","timestamp":1784542345659,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To characterize the spectra of mutations in non-muscle invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) in the Chinese population to identify any mutational features and find potential therapeutic targets.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> We collected fresh bladder tumor samples from NMIBC (n = 9) and MIBC patients (n = 11) along with adjacent normal bladder tissue specimen and peripheral blood sample. Using whole exome sequencing (WES), we analyzed the mutation spectra of those NMIBC and MIBC bladder cancer (BCa) specimen.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our results demonstrated that 95% of BCa patients (19\/20) had varying degrees of driver gene mutations, FGFR3 (45%), KMT2D (40%), PIK3CA (35%), ARID1A (20%), EP300 (20%), KDM6A (20%), KMT2C (20%), and STAG2 (20%) were the most frequently mutated genes in BCa patients. NMIBC and MIBC exhibited different genomic alterations. FGFR3 (67%), PIK3CA (56%), and RHOB (44%) were the most frequently mutated genes in NMIBC patients. Of note, RHOB mutation only occurred in NMIBC, whereas mutations of KMT2D (55%), TP53 (36%) and KMT2B (27%) were frequently detected in MIBC, and TP53 and KMT2B mutation only occurred in MIBC. The frequency of mutations in DNA-damage repair (DDR) gene was higher in MIBC than that in NMIBC (91 vs 78%, 6.2 vs 2.4 gene mutations per patient). Copy number alterations (CNAs) occurred at more diverse chromosomal locations in NMIBC, but the CNA burden was higher in MIBC [9.01 (2.07\u201331.51) vs 4.98 (0.99\u20139.73) mutations\/Mb]., the trend of which was consistent with the tumor mutation burden (TMB) [8.26 (4.63\u201321.84) vs 5.58 (3.87\u20139.58) mutations\/Mb]. Among the current set of single-base substitution (SBS) signatures including SBS 1, 2, 5, 13, and 40, we identified one differently expressed signature between NMIBC and MIBC patients: SBS13.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> There were different gene mutational characteristics and signatures between NMIBC and MIBC in the Chinese population. Frequency of DDR, CNA burden and TMB were higher in MIBC. Our analysis revealed that several genes in NMIBC did not overlap with those reported in MIBC, suggesting that a fraction of NMIBC and MIBC likely developed secondary to different precursor lesions.<\/jats:p>","DOI":"10.3389\/fgene.2022.831146","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:04:41Z","timestamp":1648605881000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing"],"prefix":"10.3389","volume":"13","author":[{"given":"Fangming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianzeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/pap.0b013e31827bd0ec","article-title":"Molecular Basis of Urinary Bladder Cancer","volume":"20","author":"Al Hussain","year":"2013","journal-title":"Adv. Anat. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of Mutational Processes in Human Cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The Repertoire of Mutational Signatures in Human Cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur. Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.urolonc.2018.02.017","article-title":"The Evolution of Bladder Cancer Genomics: What Have We Learned and How Can We Use it?","volume":"36","author":"Audenet","year":"2018","journal-title":"Urol. Oncol. Semin. Original Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cell.2018.02.06010.1016\/j.cell.2018.07.034","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"174","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.eururo.2020.11.008","article-title":"Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer?","volume":"79","author":"Baker","year":"2021","journal-title":"Eur. Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eururo.2020.03.049","article-title":"Procarcinogen Activation and Mutational Signatures Model the Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro","volume":"78","author":"Baker","year":"2020","journal-title":"Eur. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1158\/0008-5472.can-20-0977","article-title":"Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-muscle-invasive Bladder Cancer","volume":"80","author":"Bellmunt","year":"2020","journal-title":"Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/humu.23026","article-title":"Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2","volume":"37","author":"B\u00f6gershausen","year":"2016","journal-title":"Hum. Mutat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT\u2010related Gene Signature for the Prognosis of Human Bladder Cancer","volume":"24","author":"Cao","year":"2020","journal-title":"J. Cell. Mol. Medi."},{"key":"B13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer Statistics in China, 2015CA Cancer J Clin","volume":"66","author":"Chen","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12885-021-08372-9","article-title":"Significance of KDM6A Mutation in Bladder Cancer Immune Escape","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ijc.2910560309","article-title":"p53 Mutations in Human Bladder Cancer: Genotypicversus Phenotypic Patterns","volume":"56","author":"Cordon-Cardo","year":"1994","journal-title":"Int. J. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/03008880802291915","article-title":"Molecular Alterations Associated with Bladder Cancer Initiation and Progression","volume":"42","author":"Cordon-Cardo","year":"2008","journal-title":"Scand. J. Urol. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.gene.2017.06.056","article-title":"Histone H3 Lysine 4 Methyltransferase KMT2D","volume":"627","author":"Froimchuk","year":"2017","journal-title":"Gene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/7.4.737","article-title":"The UTX Gene Escapes X Inactivation in Mice and Humans","volume":"7","author":"Greenfield","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent Mutations of Chromatin Remodeling Genes in Transitional Cell Carcinoma of the Bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","article-title":"Whole-genome and Whole-Exome Sequencing of Bladder Cancer Identifies Frequent Alterations in Genes Involved in Sister Chromatid Cohesion and Segregation","volume":"45","author":"Guo","year":"2013","journal-title":"Nat. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.3390\/ijms21176072","article-title":"Mutational Landscape and Environmental Effects in Bladder Cancer","volume":"21","author":"Hayashi","year":"2020","journal-title":"Ijms"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3389\/fonc.2020.01643","article-title":"Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer","volume":"10","author":"Hirotsu","year":"2020","journal-title":"Front. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"18439","DOI":"10.1073\/pnas.0707292104","article-title":"Identification of JmjC Domain-Containing UTX and JMJD3 as Histone H3 Lysine 27 Demethylases","volume":"104","author":"Hong","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","article-title":"Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency","volume":"32","author":"Hurst","year":"2017","journal-title":"Cancer Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1038\/sj.onc.1208705","article-title":"FGFR3 and Ras Gene Mutations Are Mutually Exclusive Genetic Events in Urothelial Cell Carcinoma","volume":"24","author":"Jebar","year":"2005","journal-title":"Oncogene"},{"key":"B26","doi-asserted-by":"publisher","first-page":"768981","DOI":"10.3389\/fcell.2021.768981","article-title":"Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes","volume":"9","author":"Jiang","year":"2021","journal-title":"Front. Cel. Dev. Biol."},{"key":"B27","first-page":"177","article-title":"Pathways of Development and Progression in Bladder Cancer: New Correlations between Clinical Observations and Molecular Mechanisms","volume":"11","author":"Jones","year":"1993","journal-title":"Semin. Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","article-title":"T1 Bladder Cancer: Current Considerations for Diagnosis and Management","volume":"16","author":"Jordan","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and Molecular Landscape of DNA Damage Repair Deficiency across the Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular Biology of Bladder Cancer: New Insights into Pathogenesis and Clinical Diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational Heterogeneity in Cancer and the Search for New Cancer-Associated Genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E1560","DOI":"10.1073\/pnas.1718185115","article-title":"E-cigarette Smoke Damages DNA and Reduces Repair Activity in Mouse Lung, Heart, and Bladder as Well as in Human Lung and Bladder Cells","volume":"115","author":"Lee","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajur.2015.04.016","article-title":"Current Status of Diagnosis and Treatment of Bladder Cancer in China - Analyses of Chinese Bladder Cancer Consortium Database","volume":"2","author":"Li","year":"2015","journal-title":"Asian J. Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A Compendium of Mutational Cancer Driver Genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"Mclaren","year":"2016","journal-title":"Genome Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cancers9040028","article-title":"DNA Repair Pathway Alterations in Bladder Cancer","volume":"9","author":"Mouw","year":"2017","journal-title":"Cancers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/iju.13955","article-title":"Impact of Sex Difference on Survival of Bladder Cancer: A Population\u2010based Registry Data in Japan","volume":"26","author":"Nakayama","year":"2019","journal-title":"Int. J. Urol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1158\/1078-0432.ccr-18-3147","article-title":"Mutational Analysis of 472 Urothelial Carcinoma across Grades and Anatomic Sites","volume":"25","author":"Nassar","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3892\/ol.2016.4094","article-title":"Novel Somatic Mutations Identified by Whole-Exome Sequencing in Muscle-Invasive Transitional Cell Carcinoma of the Bladder","volume":"11","author":"Pan","year":"2016","journal-title":"Oncol. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jjco\/hyw034","article-title":"Urologic Cancer in China","volume":"46","author":"Pang","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur. Urol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1158\/1078-0432.ccr-09-0898","article-title":"Spectrum of Phosphatidylinositol 3-kinase Pathway Gene Alterations in Bladder Cancer","volume":"15","author":"Platt","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The Present and Future burden of Urinary Bladder Cancer in the World","volume":"27","author":"Ploeg","year":"2009","journal-title":"World J. Urol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC Cytidine Deaminase Mutagenesis Pattern Is Widespread in Human Cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: Fast and Accurate Calling of Germline and Somatic Variants[J]","volume":"15","author":"Sangtae","year":"2018","journal-title":"Nat. Methods"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: Allele-specific Copy Number and Clonal Heterogeneity Analysis Tool for High-Throughput DNA Sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1158\/0008-5472.can-09-1091","article-title":"Polymorphisms in DNA Repair Genes, Smoking, and Bladder Cancer Risk: Findings from the International Consortium of Bladder Cancer","volume":"69","author":"Stern","year":"2009","journal-title":"Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A. Cancer J. Clin."},{"key":"B50","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.cd-15-0344","article-title":"APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity","volume":"5","author":"Swanton","year":"2015","journal-title":"Cancer Discov."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1158\/1078-0432.ccr-16-2520","article-title":"DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma","volume":"23","author":"Teo","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1200\/jco.2017.75.7740","article-title":"Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit from PD-1\/pd-L1 Blockade in Advanced Urothelial Cancers","volume":"36","author":"Teo","year":"2018","journal-title":"Jco"},{"key":"B53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term Cancer-specific Survival in Patients with High-Risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: a Systematic Review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur. Urol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/15384047.2020.1763148","article-title":"Identification of Potential Therapeutic Targets in Urothelial Bladder Carcinoma of Chinese Population by Targeted Next-Generation Sequencing","volume":"21","author":"Wang","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41467-019-08576-5","article-title":"Whole-genome Sequencing Identifies ADGRG6 Enhancer Mutations and FRS2 Duplications as Angiogenesis-Related Drivers in Bladder Cancer","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.831146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:04:48Z","timestamp":1648605888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.831146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":56,"alternative-id":["10.3389\/fgene.2022.831146"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.831146","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"article-number":"831146"}}